BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25777776)

  • 1. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
    Odobasic D; Muljadi RC; O'Sullivan KM; Kettle AJ; Dickerhof N; Summers SA; Kitching AR; Holdsworth SR
    Arthritis Rheumatol; 2015 Jul; 67(7):1868-80. PubMed ID: 25777776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis.
    Gan PY; Holdsworth SR; Kitching AR; Ooi JD
    Cell Immunol; 2013 Mar; 282(1):21-7. PubMed ID: 23665205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis.
    Dos Santos M; Poletti PT; Favero G; Stacchiotti A; Bonomini F; Montanari CC; Bona SR; Marroni NP; Rezzani R; Veronese FV
    Autoimmunity; 2018 Mar; 51(2):69-80. PubMed ID: 29480020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
    Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
    Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis.
    Gan PY; Steinmetz OM; Tan DS; O'Sullivan KM; Ooi JD; Iwakura Y; Kitching AR; Holdsworth SR
    J Am Soc Nephrol; 2010 Jun; 21(6):925-31. PubMed ID: 20299361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
    Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
    Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model.
    Dos Santos M; Favero G; Bonomini F; Stacchiotti A; Rodella LF; Veronese FV; Rezzani R
    Life Sci; 2018 Jan; 193():242-251. PubMed ID: 29097157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
    Liu C; Kanamaru Y; Watanabe T; Tada N; Horikoshi S; Suzuki Y; Liu Z; Tomino Y
    Clin Exp Immunol; 2015 Sep; 181(3):407-16. PubMed ID: 25907714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.
    Kubota K; Saiwai H; Kumamaru H; Maeda T; Ohkawa Y; Aratani Y; Nagano T; Iwamoto Y; Okada S
    Spine (Phila Pa 1976); 2012 Jul; 37(16):1363-9. PubMed ID: 22322369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.
    Chowdhary VR; Grande JP; Luthra HS; David CS
    Rheumatology (Oxford); 2007 Sep; 46(9):1405-10. PubMed ID: 17576695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
    Odobasic D; Yang Y; Muljadi RC; O'Sullivan KM; Kao W; Smith M; Morand EF; Holdsworth SR
    Arthritis Rheumatol; 2014 Apr; 66(4):907-17. PubMed ID: 24757143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.
    O'Sullivan KM; Lo CY; Summers SA; Elgass KD; McMillan PJ; Longano A; Ford SL; Gan PY; Kerr PG; Kitching AR; Holdsworth SR
    Kidney Int; 2015 Nov; 88(5):1030-46. PubMed ID: 26176828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
    Wang H; Knight JS; Hodgin JB; Wang J; Guo C; Kleiman K; Eitzman DT
    Sci Rep; 2016 Jun; 6():28997. PubMed ID: 27357136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.